China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Lab-scale production of medicarpin in yeast heralds another manufacturing option for this natural anti-tumor agent.

Sigachi Industries introduces a new Cystic Fibrosis API combination, enhancing its strategic focus on complex specialty ...

Munich, Germany, Jan. 20, 2026 (GLOBE NEWSWIRE) -- smartbax, a biotech company developing next-generation antibiotics against ...

Sigachi Industries announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharmaceutical Ingredients (APIs) ...

Sigachi Industries Ltd., a well-known pharmaceutical company in India, announced today a significant milestone in its ...

A single enzyme that can generate all four nucleotide triphosphates, the building blocks of ribonucleic acid (RNA), was ...

Google has launched Personal Intelligence for AI Mode, allowing paid subscribers to connect Gmail and Google Photos for ...

The CF API combination involves advanced chemistry, multi-step synthesis, and specialised reactions, resulting in high technological complexity and significant barriers to entry, thereby limiting ...

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

A single enzyme that can generate all four nucleotide triphosphates, the building blocks of ribonucleic acid (RNA), was ...

Our planet is unique for its ability to sustain abundant life. From studies of the rock record, scientists believe life had ...